Perkosie, PA, United States of America

Frank J Villani, Jr


Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Hatfield, PA (US) (1987)
  • Perkosie, PA (US) (1994)

Company Filing History:


Years Active: 1987-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Frank J Villani, Jr: Innovator in Antipsychotic and Anxiolytic Agents

Introduction

Frank J Villani, Jr. is a notable inventor based in Perkasie, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antipsychotic and anxiolytic agents. With a total of 2 patents, his work has the potential to impact the treatment of various mental health conditions.

Latest Patents

Villani's latest patents include innovative compounds that serve as novel antipsychotic agents. One of his patents focuses on cyclic benzylamino, benzylamido, and benzylimido antipsychotic agents, which are disclosed as compounds of a specific general formula. These compounds are not only useful as antipsychotic agents but also include pharmaceutical compositions and methods for treating convulsions. Another significant patent involves anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives, which are ureas of a defined formula. These derivatives are valuable as anxiolytic agents and serve as intermediates in synthesis processes.

Career Highlights

Villani has established a career at McNeil Ab, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for mental health disorders, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Villani has collaborated with notable colleagues, including Malcolm K Scott and Allen B Reitz. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Frank J Villani, Jr. stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of antipsychotic and anxiolytic agents. His contributions through his patents reflect a commitment to enhancing mental health treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…